554
Views
18
CrossRef citations to date
0
Altmetric
Original Research

A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database

, , , , &
Pages 1161-1169 | Received 18 Sep 2018, Accepted 15 Nov 2018, Published online: 27 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Devanshi Jain, Gazal Sharma & Anoop Kumar. (2023) Adverse effects of proton pump inhibitors (PPIs) on the renal system using data mining algorithms (DMAs). Expert Opinion on Drug Safety 22:8, pages 741-752.
Read now
Zhiping Li, Wenbin Zou, Jiao Yuan, Yunxiang Zhong & Zhiwen Fu. (2023) Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system. Expert Opinion on Drug Safety 0:0, pages 1-8.
Read now
Vera Battini, Giovanna Cirnigliaro, Luca Giacovelli, Maria Boscacci, Silvia Massara Manzo, Giulia Mosini, Greta Guarnieri, Michele Gringeri, Beatrice Benatti, Emilio Clementi, Bernardo Dell’Osso & Carla Carnovale. (2023) Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS. Expert Review of Clinical Pharmacology 16:5, pages 453-465.
Read now
Faizan Mazhar, Vera Battini, Michele Gringeri, Marco Pozzi, Giulia Mosini, Albaraa Mohammed N. Marran, Shahzad Akram, Robbert P. van Manen, Sonia Radice, Emilio Clementi & Carla Carnovale. (2021) The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database. Expert Opinion on Biological Therapy 21:9, pages 1281-1290.
Read now

Articles from other publishers (14)

Nikica Mirosevic Skvrce, Lana Omrcen, Morana Pavicic & Iva Mucalo. (2023) Root cause analysis of medication errors of the most frequently involved active substances in paediatric patients. Research in Social and Administrative Pharmacy.
Crossref
Michele Fusaroli, Guido Pelletti, Valentina Giunchi, Emanuel Raschi, Fabrizio De Ponti, Susi Pelotti & Elisabetta Poluzzi. (2023) Authors’ Reply to Cappello et al. Comment on: “Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”. Drug Safety.
Crossref
David J. Cvancara, Hans C. Baertsch, Ashton E. Lehmann, Ian M. Humphreys, Nyssa Fox Farrell, Thomas B. Marshall, Neel K. Bhatt, Waleed M. Abuzeid & Aria Jafari. (2023) Postmarketing Reporting of Paxlovid‐Related Dysgeusia: A Real‐World Pharmacovigilance Study. Otolaryngology–Head and Neck Surgery 169:1, pages 55-61.
Crossref
Vera Battini, Robbert P. Van Manen, Michele Gringeri, Giulia Mosini, Greta Guarnieri, Anna Bombelli, Marco Pozzi, Maria Nobile, Sonia Radice, Emilio Clementi & Carla Carnovale. (2023) The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase. Frontiers in Pharmacology 14.
Crossref
Carla Carnovale, Vera Battini, Michele Gringeri, Marina Volonté, Maria Chiara Uboldi, Andrea Chiarenza & Giovanni Passalacqua. (2022) Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review. World Allergy Organization Journal 15:7, pages 100658.
Crossref
Chiara Mameli, Carla Carnovale, Federico Ambrogi, Gabriele Infante, Paulina Roux Biejat, Alessandra Napoli, Marco Coazzoli, Valeria Calcaterra, Laura Schneider, Chiara Perazzi, Gianvincenzo Zuccotti, Emilio Clementi, Claudia Moscheni & Cristiana Perrotta. (2022) Increased acid sphingomyelinase levels in pediatric patients with obesity. Scientific Reports 12:1.
Crossref
Vera Battini, Alessandra Mari, Michele Gringeri, Francesca Casini, Francesco Bergamaschi, Giulia Mosini, Greta Guarnieri, Marco Pozzi, Maria Nobile, Gianvincenzo Zuccotti, Emilio Clementi, Sonia Radice, Valentina Fabiano & Carla Carnovale. (2022) Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review. Frontiers in Pharmacology 13.
Crossref
Olga Tchijevitch, Sebrina Maj-Britt Hansen, Søren Bie Bogh, Jesper Hallas & Søren Birkeland. (2022) Methodological approaches for medication error analyses in patient safety and pharmacovigilance reporting systems: a scoping review protocol. BMJ Open 12:5, pages e057764.
Crossref
Haoning Guo, Bin Wang, Shuying Yuan, Silin Wu, Jing Liu, Miaoquan He & Jisheng Wang. (2022) Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System. Frontiers in Pharmacology 13.
Crossref
Maddalena Alessandra Wu, Carla Carnovale, Claudia Gabiati, Daniela Montori & Antonio Brucato. (2021) Appropriateness of care: from medication reconciliation to deprescribing. Internal and Emergency Medicine 16:8, pages 2047-2050.
Crossref
Morgane Masse, Cécile Yelnik, Julien Labreuche, Loïc André, Edgar Bakhache, Bertrand Décaudin, Elodie Drumez, Pascal Odou, Mathilde Dambrine & Marc Lambert. (2021) Risk factors associated with unintentional medication discrepancies at admission in an internal medicine department. Internal and Emergency Medicine 16:8, pages 2213-2220.
Crossref
Xiaofang Tan, Dongshi Gu, Xiaowen Lin, Huan Fang & Tetsuya Asakawa. (2020) Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China. Saudi Pharmaceutical Journal 28:10, pages 1190-1196.
Crossref
Nils Kuklik, Jürgen Stausberg, Marjan Amiri & Karl-Heinz Jöckel. (2019) Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data. BMC Health Services Research 19:1.
Crossref
Faizan Mazhar, Marco Pozzi, Marta Gentili, Marco Scatigna, Emilio Clementi, Sonia Radice & Carla Carnovale. (2019) Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance–Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database. CNS Drugs 33:6, pages 581-592.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.